View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
March 4, 2020updated 09 Feb 2022 4:42am

Chest CTs of coronavirus patients reveal nature and extent of damage

A multi-centre study has used computed tomography (CT) scans to gain insights into the nature and extent of the lung damage caused by novel coronavirus (Covid-19) pneumonia.

By Chloe Kent

A multi-centre study has used computed tomography (CT) scans to gain insights into the nature and extent of the lung damage caused by novel coronavirus (Covid-19) pneumonia.

Free Report
img

Navigate your business through the ‘new normal’

COVID-19 continues to dominate headlines the world over. It has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities.  Faced with an explosion of conflicting information on how to plan and implement successful recovery strategies, decision-makers are in dire need of a single, reliable source of intelligence.   GlobalData’s COVID-19 Executive Briefing gives you access to unparalleled data and insights to successfully navigate the uncertain road to recovery across the world’s largest industries. Understand every aspect of this disruptive theme by delving into: 
  •  COVID-19 infection update, with statistics on the spread, testing by country, as well as the latest data on vaccines and therapeutic developments 
  • Economic impact overview, covering stock market indices, GDP, unemployment rates, policy responses & GlobalData’s economic recovery scorecards 
  • Sector developments, with access to sector insight summaries, cross-sector indices and the leaders and laggards in each industry vertical 
Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today. 
by GlobalData
Enter your details here to receive your free Report.

The results were collected from 101 cases of Covid-19 pneumonia across four institutions in China’s Hunan province.

The scans determined that 86% of Covid-19 patients have ground-glass opacities (GGO), while 64% have mixed GGO and consolidation and 71% have vascular enlargement in the lesion.

Ground glass opacities indicate partial filling of air spaces in the lungs by exudate or transudate, as well as interstitial thickening or partial collapse of the lung alveoli.

The lesions present on the CT images were more likely to have peripheral distribution (87%) and bilateral involvement (82%). They were also more likely to be lower lung predominant (54%) and multifocal (54%).

Just over 70% of the patients were aged between 21 and 50, and 78% had fever as the onset symptom. Only five patients showed disease associated with a family outbreak.

The researchers also compared the clinical characteristics and imaging features between non-emergency patients with mild cases of the disease and emergency cases of severe or fatal disease.

Emergency patients were older than the patients in the non-emergency group, but the rate of underlying disease was not significantly different between the two. This suggests that viral load could be a better reflection of the severity and extent of Covid-19 pneumonia.

Lead study authors Wei Zhao and Zheng Zhong said: “Architectural distortion, traction bronchiectasis, and pleural effusions, which may reflect the viral load and virulence of Covid-19, were statistically different between the two groups and may help us to identify the emergency type disease.”

Zhao and Zhong said that CT involvement score could help evaluate the severity and extent of individual patients’ Covid-19 pneumonia.

The results of the study are set to be published in the American Journal of Roentgenology.

Related Companies

Free Report
img

Navigate your business through the ‘new normal’

COVID-19 continues to dominate headlines the world over. It has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities.  Faced with an explosion of conflicting information on how to plan and implement successful recovery strategies, decision-makers are in dire need of a single, reliable source of intelligence.   GlobalData’s COVID-19 Executive Briefing gives you access to unparalleled data and insights to successfully navigate the uncertain road to recovery across the world’s largest industries. Understand every aspect of this disruptive theme by delving into: 
  •  COVID-19 infection update, with statistics on the spread, testing by country, as well as the latest data on vaccines and therapeutic developments 
  • Economic impact overview, covering stock market indices, GDP, unemployment rates, policy responses & GlobalData’s economic recovery scorecards 
  • Sector developments, with access to sector insight summaries, cross-sector indices and the leaders and laggards in each industry vertical 
Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today. 
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU